Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 12130281 Gene editing through microfluidic delivery

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Armon R. Sharei0

Robert S. Langer0

Marc Lajoie0

Klavs F. Jensen0

Date of Patent

October 29, 2024

0

Patent Application Number

174042860

Date Filed

August 17, 2021

0

Patent Citations

US Patent 7993821 Methods and apparatus for the isolation and enrichment of circulating tumor cells

0

US Patent 8211656 Biological targeting compositions and methods of using the same

0

US Patent 8669044 Methods and apparatus for the isolation and enrichment of circulating tumor cells

0

US Patent 8679751 System and method for particle filtration

0

US Patent 8697359 CRISPR-Cas systems and methods for altering expression of gene products

0

US Patent 8844570 Generating binary states using a microfluidic channel

0

US Patent 9005579 Methods and compositions for enhanced immunological therapy and targeting of gram-positive bacteria

0

US Patent 9017991 Methods tip assemblies and kits for introducing material into cells

0

...

Patent Primary Examiner

Catherine S Hibbert

0

CPC Code

0

0

0

0

Patent abstract

Gene editing can be performed by introducing gene-editing components into a cell by mechanical cell disruption. Related apparatus, systems, techniques, and articles are also described.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 12130281 Gene editing through microfluidic delivery

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool